Conversion of oxadiazolopyrazines to imidazopyrazines via a tandem reduction-cyclization sequence generates new mitochondrial uncouplers. Santiago-Rivera, Stefan Hargett, Joseph M. Synthesis and conformational studies of 5-bromo-1-7-azabenzimidazoles. Lobb, Tendamudzimu Tshiwawa, Michelle Isaacs, Heinrich C. Activation of the essential kinase PDK1 by phosphoinositide-driven trans-autophosphorylation. Small Molecule Kinase Inhibitors for the Treatment of Brain Cancer. Journal of Chemical Information and Modeling 2019, 59 Investigation of Crystal Structures in Structure-Based Virtual Screening for Protein Kinase Inhibitors. Xingye Chen, Haichun Liu, Wuchen Xie, Yan Yang, Yuchen Wang, Yuanrong Fan, Yi Hua, Lu Zhu, Junnan Zhao, Tao Lu, Yadong Chen, Yanmin Zhang.

Design, Synthesis, and Evaluation of Potent, Selective, and Bioavailable AKT Kinase Degraders. Xufen Yu, Jia Xu, Ling Xie, Li Wang, Yudao Shen, Kaitlyn M.Discovery of Potent, Selective, and In Vivo Efficacious AKT Kinase Protein Degraders via Structure–Activity Relationship Studies. Cahuzac, Kwang-su Park, Brandon Dale, Jing Liu, Ramon E. Xufen Yu, Jia Xu, Yudao Shen, Kaitlyn M.Principles of Kinase Allosteric Inhibition and Pocket Validation. Discovery of Clinical Candidate NTQ1062 as a Potent and Bioavailable Akt Inhibitor for the Treatment of Human Tumors. Changyou Ma, Jian Wu, Lei Wang, Xiaojun Ji, Yebin Wu, Lei Miao, Donghui Chen, Linlin Zhang, Youzhi Wu, Haiwei Feng, Ying Tang, Qiuhua Zhou, Junjie Pei, Xule Yang, Dan Xu, Qidong You, Yuan Xie.Journal of Chemical Information and Modeling 2022, 62 AI-Based Protein Structure Prediction in Drug Discovery: Impacts and Challenges. Michael Schauperl, Rajiah Aldrin Denny.Novel Allosteric Inhibitor-Derived AKT Proteolysis Targeting Chimeras (PROTACs) Enable Potent and Selective AKT Degradation in KRAS/BRAF Mutant Cells. Cahuzac, Ling Xie, Yudao Shen, Xian Chen, Jing Liu, Ramon E. This article is cited by 54 publications.

Arq pierrot